| Literature DB >> 27323007 |
Kengo Maeda1, Hiromichi Kawai2, Mitsuru Sanada2, Tomoya Terashima2, Nobuhiro Ogawa1, Ryo Idehara3, Tetsuya Makiishi4, Hitoshi Yasuda2, Shun-Ichi Sato5, Ken-Ichi Hoshi5, Hiroyuki Yahikozawa5, Katsuji Nishi6, Yasushi Itoh7, Kazumasa Ogasawara7, Kazuo Tomita8, Hiroko P Indo8, Hideyuki J Majima8.
Abstract
IMPORTANCE: The regulatory factors explaining the wide spectrum of clinical phenotypes for mitochondrial 3243A>G mutation are not known. Crosstalk between nuclear genes and mitochondrial DNA might be one factor. OBSERVATIONS: In this case series, we compared 2 pairs of male twins with the mitochondrial 3243 A>G mutation and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome with a female control patient. One pair of monozygotic twins presented with diabetes and deafness in their 30s, stroke-like episodes in their 40s, and cardiac events and death in their 50s. Another pair of twins presented with deafness and stroke-like episodes in their 20s. The degree of heteroplasmy of 3243A>G mutation in the various tissues and organs was similar in the first pair of twins compared with the control patient. CONCLUSIONS AND RELEVANCE: The clinical phenotype and segregation of mitochondrial 3243A>G mutation was similar in monozygotic twins. The onset age and distribution of the symptoms might be regulated by nuclear genes. Our findings might help to predict the clinical course of the surviving twins and afford an opportunity for therapy before the onset of mitochondrial disease, especially for monozygotic twins caused by nuclear transfer with a small amount of nuclear-donor mitochondrial DNA.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27323007 DOI: 10.1001/jamaneurol.2016.0886
Source DB: PubMed Journal: JAMA Neurol ISSN: 2168-6149 Impact factor: 18.302